NPPB and hydrops fetalis: Importantly, these proteins improve discriminative capability for HFpEF when added to clinical variables and NT-proBNP, suggesting their potential value as components of multi-protein biomarker clinical tools, and a subset of these same proteins predict incident HF hospitalizations and all-cause mortality.